Effectiveness of immunoglobulin prophylaxis in reducing clinical complications of hematopoietic stem cell transplantation: a systematic review and meta-analysis

Transfusion
Hilalion AhnJuthaporn Cowan

Abstract

Prophylactic immunoglobulin has been used with varying efficacy to reduce complications in hematopoietic stem cell transplant recipients. A systematic review and meta-analysis was conducted of randomized controlled trials that assessed clinical outcomes (overall survival, transplant-related mortality, graft-versus-host disease [GVHD], veno-occlusive disease [VOD], interstitial pneumonitis, disease relapse, cytomegalovirus [CMV] infection and disease, non-CMV infection) of immunoglobulin prophylaxis versus placebo in hematopoietic stem cell transplant recipients. MEDLINE, EMBASE, EBM Reviews, and the Cochrane Central Register of Controlled Trials were searched up to June 2017. Quality of included studies and outcomes were evaluated via Risk of Bias assessment and Grading of Recommendations, Assessment, Development and Evaluation criteria, respectively. Of 899 citations screened, 27 studies (n = 3934) were included. Immunoglobulin prophylaxis had no impact on survival (risk ratio [RR], 0.94; 95% confidence interval [CI], 0.88-1.01; 11 studies, n = 1962) but decreased risk of acute GVHD (RR, 0.78; 95% CI, 0.65-0.94; eight studies, n = 1097) and CMV disease (RR, 0.52; 95% CI, 0.28-0.97; two studies, n = 167). Meta-analysis revealed...Continue Reading

References

Sep 13, 1990·The New England Journal of Medicine·K M SullivanR P Witherspoon
Jul 1, 1982·Annals of Internal Medicine·D J WinstonR P Gale
Dec 1, 1996·Blood Reviews·B J HuntlyM J Pippard
Aug 13, 1998·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·K M SullivanG B McDonald
May 25, 1999·Bone Marrow Transplantation·A Abdel-MageedH M Lazarus
Dec 14, 1999·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·L C FeinsteinK M Sullivan
Jun 14, 2000·BMJ : British Medical Journal·A J SuttonD R Jones
Mar 27, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Per LjungmanCarlos Paya
Apr 10, 2002·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Denise R SokosHillard M Lazarus
Jan 29, 2003·Nursing Research·Karen L Soeken, Acharaporn Sripusanapan
Apr 15, 2005·Molecular Immunology·Réal LemieuxSonia Néron
Apr 28, 2006·The New England Journal of Medicine·Edward A Copelan
Jun 23, 2006·Seminars in Respiratory and Critical Care Medicine·Bekele Afessa, Steve G Peters
Nov 21, 2007·Hematology·Daniel Weisdorf
Apr 17, 2008·Cancer Causes & Control : CCC·D TrichopoulosH O Adami
Oct 4, 2008·Current Opinion in Hematology·Effie W Petersdorf, John A Hansen
Oct 23, 2008·Immunology and Allergy Clinics of North America·Francisco A Bonilla
Dec 31, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Pia RaananiOfer Shpilberg
Jul 11, 2009·Clinical Reviews in Allergy & Immunology·Shaye KivityYehuda Shoenfeld
Jul 22, 2009·PLoS Medicine·David MoherUNKNOWN PRISMA Group
Sep 15, 2009·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Marcie TomblynUNKNOWN Centers for Disease Control and Prevention
Dec 28, 2010·Journal of Clinical Epidemiology·Gordon H GuyattAndre Knottnerus
Oct 20, 2011·BMJ : British Medical Journal·Julian P T HigginsUNKNOWN Cochrane Statistical Methods Group
Nov 1, 2012·Transfusion·Douglass A DrelichJay H Herman
Jun 5, 2013·Expert Review of Clinical Immunology·Hassan AbolhassaniAsghar Aghamohammadi
Sep 18, 2013·Cancer Letters·Ella J Ariza-HerediaRoy F Chemaly
Jun 11, 2014·Blood·Boglarka Gyurkocza, Brenda M Sandmaier

❮ Previous
Next ❯

Citations

Jul 23, 2021·Paediatric Drugs·Athanasios Tragiannidis, Andreas H Groll

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.